Metabolomic Signatures Discriminate Horses with Clinical Signs of Atypical Myopathy from Healthy Co-grazing Horses.

This research investigates the difference in blood metabolic profiles between horses with clinical signs of Atypical Myopathy (AM), and healthy co-grazing horses. Through comparative analysis, the study identifies specific metabolites and their relevant metabolic pathways that indicate the presence of this severe muscle disease.

Research Objectives and Methodology

• The main aim of the study is to distinguish horses showing clinical signs of Atypical Myopathy (AM) from healthy horses sharing the same pasture, by comparing their blood metabolomic profiles. AM is a severe muscle degradation syndrome found in grazing horses, not all of whom display symptoms despite having toxins in their blood.
• To achieve this, researchers collected and analyzed plasma samples from horses with AM and healthy co-grazing horses. They utilized an analytical technique called untargeted metabolomics, which allows for an unbiased examination of all detectable metabolites (small molecules involved in metabolic reactions) in a biological sample. This gives an overall picture of the sample’s metabolome, or the complete set of metabolites.

Data Analysis and Results

• The research team used three types of analysis on the obtained metabolomic data: unsupervised analysis, supervised analysis, and pathway analysis.
• The unsupervised analysis, using Principal Component Analysis (PCA), distinguished horses with AM from the healthy ones, on the basis of detected features.
• The supervised analysis identified 1276 features showing different expression between the two horse groups. Utilizing a standard comparison, the researchers managed to identify 46 of these metabolites.
• These identified metabolites predominantly belonged to the fatty acid, fatty ester, and amino acid chemical classes. Horses with AM showed a higher intensity of fatty acids, unsaturated fatty acids, organic dicarboxylic acids, and fatty esters. This observation was linked with toxins’ pathological mechanism in these horses.

Significant Findings and Implications

• Important metabolic pathways identified were related to lipid metabolism, and the metabolism of certain amino acids (valine, leucine, and isoleucine) and glycine. The metabolites and pathways underlined can be viewed as characteristic of AM clinically affected horses.
• The results of this research could be useful in the early detection and management of AM in horses, as well as understanding the pathology and progression of the disease.
• The raw metabolomic data derived from the study has been made available in the MetaboLights database, to support future research in the same domain.